BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33846537)

  • 1. An engineered channelrhodopsin optimized for axon terminal activation and circuit mapping.
    Hamada S; Nagase M; Yoshizawa T; Hagiwara A; Isomura Y; Watabe AM; Ohtsuka T
    Commun Biol; 2021 Apr; 4(1):461. PubMed ID: 33846537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optogenetic probing and manipulation of the calyx-type presynaptic terminal in the embryonic chick ciliary ganglion.
    Egawa R; Hososhima S; Hou X; Katow H; Ishizuka T; Nakamura H; Yawo H
    PLoS One; 2013; 8(3):e59179. PubMed ID: 23555628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optogenetic analysis of neuromuscular transmission in the colon of ChAT-ChR2-YFP BAC transgenic mice.
    Perez-Medina AL; Galligan JJ
    Am J Physiol Gastrointest Liver Physiol; 2019 Nov; 317(5):G569-G579. PubMed ID: 31411893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Achieving high-frequency optical control of synaptic transmission.
    Jackman SL; Beneduce BM; Drew IR; Regehr WG
    J Neurosci; 2014 May; 34(22):7704-14. PubMed ID: 24872574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studying Neuronal Function Ex Vivo Using Optogenetic Stimulation and Patch Clamp.
    Aksoy-Aksel A; Genty J; Zeller M; Ehrlich I
    Methods Mol Biol; 2020; 2173():1-20. PubMed ID: 32651907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient, Consequential Increases in Extracellular Potassium Ions Accompany Channelrhodopsin2 Excitation.
    Octeau JC; Gangwani MR; Allam SL; Tran D; Huang S; Hoang-Trong TM; Golshani P; Rumbell TH; Kozloski JR; Khakh BS
    Cell Rep; 2019 May; 27(8):2249-2261.e7. PubMed ID: 31116972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term channelrhodopsin-2 (ChR2) expression can induce abnormal axonal morphology and targeting in cerebral cortex.
    Miyashita T; Shao YR; Chung J; Pourzia O; Feldman DE
    Front Neural Circuits; 2013; 7():8. PubMed ID: 23386813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabotropic glutamate receptor subtypes in axon terminals of projection fibers from the main and accessory olfactory bulbs: a light and electron microscopic immunohistochemical study in the rat.
    Wada E; Shigemoto R; Kinoshita A; Ohishi H; Mizuno N
    J Comp Neurol; 1998 Apr; 393(4):493-504. PubMed ID: 9550154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of channelrhodopsin-2 localized within the deep CA1 hippocampal sublayer in the Thy1 line 18 mouse.
    Dobbins DL; Klorig DC; Smith T; Godwin DW
    Brain Res; 2018 Jan; 1679():179-184. PubMed ID: 29191773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of drugs of abuse on channelrhodopsin-2 function.
    Gioia DA; Xu M; Wayman WN; Woodward JJ
    Neuropharmacology; 2018 Jun; 135():316-327. PubMed ID: 29580953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo neurovascular response to focused photoactivation of Channelrhodopsin-2.
    Mester JR; Bazzigaluppi P; Weisspapir I; Dorr A; Beckett TL; Koletar MM; Sled JG; Stefanovic B
    Neuroimage; 2019 May; 192():135-144. PubMed ID: 30669007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-fidelity optical excitation of cortico-cortical projections at physiological frequencies.
    Hass CA; Glickfeld LL
    J Neurophysiol; 2016 Nov; 116(5):2056-2066. PubMed ID: 27489370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivery of continuously-varying stimuli using channelrhodopsin-2.
    Tchumatchenko T; Newman JP; Fong MF; Potter SM
    Front Neural Circuits; 2013; 7():184. PubMed ID: 24367294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of Distinct Channelrhodopsin Variants Engages Different Patterns of Network Activity.
    Jun NY; Cardin JA
    eNeuro; 2020; 7(1):. PubMed ID: 31822522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding the Optogenetics Toolkit by Topological Inversion of Rhodopsins.
    Brown J; Behnam R; Coddington L; Tervo DGR; Martin K; Proskurin M; Kuleshova E; Park J; Phillips J; Bergs ACF; Gottschalk A; Dudman JT; Karpova AY
    Cell; 2018 Nov; 175(4):1131-1140.e11. PubMed ID: 30343901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unraveling ChR2-driven stochastic Ca2+ dynamics in astrocytes: A call for new interventional paradigms.
    Moshkforoush A; Balachandar L; Moncion C; Montejo KA; Riera J
    PLoS Comput Biol; 2021 Feb; 17(2):e1008648. PubMed ID: 33566841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optogenetic Stimulation of Cholinergic Amacrine Cells Improves Capillary Blood Flow in Diabetic Retinopathy.
    Ivanova E; Bianchimano P; Corona C; Eleftheriou CG; Sagdullaev BT
    Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):44. PubMed ID: 32841313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optogenetically transduced human ES cell-derived neural progenitors and their neuronal progenies: Phenotypic characterization and responses to optical stimulation.
    Ryu J; Vincent PFY; Ziogas NK; Xu L; Sadeghpour S; Curtin J; Alexandris AS; Stewart N; Sima R; du Lac S; Glowatzki E; Koliatsos VE
    PLoS One; 2019; 14(11):e0224846. PubMed ID: 31710637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a novel optogenetic indicator based on cellular deformations for mapping optogenetic activities.
    Li G; Yang J; Wang Y; Wang W; Liu L
    Nanoscale; 2018 Dec; 10(45):21046-21051. PubMed ID: 30276394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Machine learning-guided channelrhodopsin engineering enables minimally invasive optogenetics.
    Bedbrook CN; Yang KK; Robinson JE; Mackey ED; Gradinaru V; Arnold FH
    Nat Methods; 2019 Nov; 16(11):1176-1184. PubMed ID: 31611694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.